Trial Information

Summary: Mount Sinai School of Medicine is currently recruiting subjects who have T-cell leukemia or lymphoma, who have failed two or more prior treatment regimens to participate in a clinical study to test the safety and efficacy of an experimental drug.

Study drug and study procedures will be made available to you at no cost.

To qualify, you must:

• Be 18 years or older
• Have T-cell lymphoma or leukemia
• Have adequate liver function
• Have a life expectancy of at least three months
• Have already failed or relapsed from two or more treatment regimens for your disease

You will not qualify if you:

• Are pregnant or breast-feeding
• Are HIV positive or have hepatitis B or C infection or other serious uncontrolled infection
• Have clinical evidence of active central nervous system leukemia
• Have received certain experimental drugs or other treatment regimens

For more information,

If you would like to learn more about participating in this study, please send an e-mail message using the form below.